Swiss National Bank’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.29M Buy
2025
Q2
$1.24M Buy
2025
Q1
$824K Hold
2024
Q4
$942K Buy
2024
Q3
$939K Hold
2024
Q2
$859K Hold
2024
Q1
$647K Buy
2023
Q4
$505K Sell
2023
Q3
$556K Sell
2023
Q2
$1M Buy